annual total liabilities:
$535.05M-$53.05M(-9.02%)Summary
- As of today (September 16, 2025), TVTX annual total liabilities is $535.05 million, with the most recent change of -$53.05 million (-9.02%) on December 31, 2024.
- During the last 3 years, TVTX annual total liabilities has risen by +$60.53 million (+12.76%).
- TVTX annual total liabilities is now -15.04% below its all-time high of $629.73 million, reached on December 31, 2022.
Performance
TVTX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$522.56M+$6.59M(+1.28%)Summary
- As of today (September 16, 2025), TVTX quarterly total liabilities is $522.56 million, with the most recent change of +$6.59 million (+1.28%) on June 30, 2025.
- Over the past year, TVTX quarterly total liabilities has dropped by -$13.41 million (-2.50%).
- TVTX quarterly total liabilities is now -17.02% below its all-time high of $629.73 million, reached on December 31, 2022.
Performance
TVTX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TVTX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | -2.5% |
| 3 y3 years | +12.8% | -16.1% |
| 5 y5 years | - | +45.1% |
TVTX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.0% | +12.8% | -17.0% | +1.3% |
| 5 y | 5-year | -15.0% | +35.0% | -17.0% | +45.1% |
| alltime | all time | -15.0% | >+9999.0% | -17.0% | >+9999.0% |
TVTX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $522.56M(+1.3%) |
| Mar 2025 | - | $515.98M(-3.6%) |
| Dec 2024 | $535.05M(-9.0%) | $535.05M(+0.0%) |
| Sep 2024 | - | $534.86M(-0.2%) |
| Jun 2024 | - | $535.97M(-9.1%) |
| Mar 2024 | - | $589.48M(+0.2%) |
| Dec 2023 | $588.10M(-6.6%) | $588.10M(+6.3%) |
| Sep 2023 | - | $553.08M(-10.8%) |
| Jun 2023 | - | $619.94M(+0.1%) |
| Mar 2023 | - | $619.09M(-1.7%) |
| Dec 2022 | $629.73M(+32.7%) | $629.73M(+0.7%) |
| Sep 2022 | - | $625.54M(+0.4%) |
| Jun 2022 | - | $622.78M(+0.4%) |
| Mar 2022 | - | $620.26M(+30.7%) |
| Dec 2021 | $474.52M(+19.8%) | $474.52M(+1.5%) |
| Sep 2021 | - | $467.70M(+12.8%) |
| Jun 2021 | - | $414.46M(+3.3%) |
| Mar 2021 | - | $401.36M(+1.3%) |
| Dec 2020 | $396.23M(-6.5%) | $396.23M(+1.4%) |
| Sep 2020 | - | $390.81M(+8.5%) |
| Jun 2020 | - | $360.05M(+3.7%) |
| Mar 2020 | - | $347.31M(-9.5%) |
| Dec 2019 | - | $383.60M(+4.3%) |
| Sep 2019 | - | $367.86M(-0.7%) |
| Jun 2019 | - | $370.49M(-3.0%) |
| Mar 2019 | - | $381.96M(-9.8%) |
| Dec 2018 | $423.61M(+73.6%) | $423.61M(+6.7%) |
| Sep 2018 | - | $397.12M(+95.5%) |
| Jun 2018 | - | $203.16M(+0.9%) |
| Mar 2018 | - | $201.32M(-17.5%) |
| Dec 2017 | $244.02M | $244.02M(+13.0%) |
| Sep 2017 | - | $215.99M(+2.2%) |
| Jun 2017 | - | $211.30M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $209.45M(-19.4%) |
| Dec 2016 | $259.79M(+7.2%) | $259.79M(+15.6%) |
| Sep 2016 | - | $224.82M(+2.4%) |
| Jun 2016 | - | $219.60M(+16.9%) |
| Mar 2016 | - | $187.87M(-11.6%) |
| Dec 2015 | $242.40M(+40.3%) | $212.43M(-3.7%) |
| Sep 2015 | - | $220.62M(-19.6%) |
| Jun 2015 | - | $274.36M(+10.9%) |
| Mar 2015 | - | $247.42M(+43.2%) |
| Dec 2014 | $172.72M(+330.0%) | $172.72M(+10.6%) |
| Sep 2014 | - | $156.12M(+1.1%) |
| Jun 2014 | - | $154.47M(+19.3%) |
| Mar 2014 | - | $129.44M(+222.3%) |
| Dec 2013 | $40.17M(+592.6%) | $40.17M(+47.8%) |
| Sep 2013 | - | $27.17M(+144.1%) |
| Jun 2013 | - | $11.13M(+36.2%) |
| Mar 2013 | - | $8.17M(+40.9%) |
| Dec 2012 | $5.80M(+8932.9%) | $5.80M(+8726.6%) |
| Nov 2011 | - | $65.70K(+0.8%) |
| Aug 2011 | - | $65.20K(+0.8%) |
| May 2011 | - | $64.70K(+0.8%) |
| Feb 2011 | $64.20K(+19.1%) | $64.20K(+0.8%) |
| Nov 2010 | - | $63.70K(+4.3%) |
| Aug 2010 | - | $61.10K(+6.3%) |
| May 2010 | - | $57.50K(+6.7%) |
| Feb 2010 | $53.90K(+41.8%) | $53.90K(+8.0%) |
| Nov 2009 | - | $49.90K(+7.8%) |
| Aug 2009 | - | $46.30K(+8.4%) |
| May 2009 | - | $42.70K(+12.4%) |
| Feb 2009 | $38.00K(-26.9%) | $38.00K(+13.4%) |
| Nov 2008 | - | $33.50K(-41.6%) |
| Aug 2008 | - | $57.40K(0.0%) |
| May 2008 | - | $57.40K |
| Feb 2008 | $52.00K | - |
FAQ
- What is Travere Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Travere Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Travere Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of TVTX is $535.05M
What is the all time high annual total liabilities for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual total liabilities is $629.73M
What is Travere Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, TVTX annual total liabilities has changed by -$53.05M (-9.02%)
What is Travere Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of TVTX is $522.56M
What is the all time high quarterly total liabilities for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly total liabilities is $629.73M
What is Travere Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, TVTX quarterly total liabilities has changed by -$13.41M (-2.50%)